What's Happening?
The American Association for Cancer Research (AACR) and AstraZeneca have launched a fellowship program for physician-scientists focused on digital pathology and AI training. The program offers a two-year research training experience, with one year at an academic
institution and one year with AstraZeneca. The fellowship aims to develop expertise in digital and computational pathology, providing a comprehensive research experience that supports scientific development and career advancement in cancer research.
Why It's Important?
This fellowship program represents a significant investment in the intersection of technology and oncology, aiming to advance cancer research through digital and computational pathology. By providing training in both academic and industry settings, the program equips physician-scientists with the skills needed to pursue independent research careers. This initiative highlights the growing importance of AI and digital technologies in medical research and diagnostics, potentially leading to breakthroughs in cancer treatment and patient care.
